Expertise in
13
conditions

Dr. Syed Lateef

Gastroenterology
821 Oakley Seaver Dr, 
Clermont, FL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
13
conditions
821 Oakley Seaver Dr, 
Clermont, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Syed Lateef is a Gastroenterologist in Clermont, Florida. Dr. Lateef is highly rated in 13 conditions, according to our data. His top areas of expertise are Chronic Erosive Gastritis, Childhood Volvulus, Portal Hypertension, and Indigestion.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

821 Oakley Seaver Dr, Clermont, FL 34711

Additional Areas of Focus

Dr. Lateef has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Recruiting
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: September 05, 2023
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
View 5 Less Clinical Trials
Similar Doctors
Expertise in
32
conditions
Dr. Shyam Varadarajulu
Gastroenterology
Expertise in
32
conditions
Dr. Shyam Varadarajulu
Gastroenterology

Orlando Health Medical Group Inc

86 W Underwood St, 
Orlando, FL 
 (21.2 miles away)
407-896-1100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shyam Varadarajulu is a Gastroenterologist in Orlando, Florida. Dr. Varadarajulu is highly rated in 32 conditions, according to our data. His top areas of expertise are Hereditary Pancreatitis, Pancreatic Pseudocyst, Acute Pancreatitis, Endoscopy, and Pancreatectomy.

Udayakumar Navaneethan
Expertise in
38
conditions
Dr. Udayakumar Navaneethan
Gastroenterology
Expertise in
38
conditions
Dr. Udayakumar Navaneethan
Gastroenterology

Orlando Health Medical Group Inc

86 W Underwood St, 
Orlando, FL 
 (21.2 miles away)
407-896-1100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Udayakumar Navaneethan is a Gastroenterologist in Orlando, Florida. Dr. Navaneethan is highly rated in 38 conditions, according to our data. His top areas of expertise are Sclerosing Cholangitis, Cholangitis, Ulcerative Colitis, Endoscopy, and Colonoscopy.

Expertise in
31
conditions
Dr. Robert Hawes
Gastroenterology
Expertise in
31
conditions
Dr. Robert Hawes
Gastroenterology

Orlando Health Medical Group Inc

86 W Underwood St, 
Orlando, FL 
 (21.2 miles away)
407-896-1100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Robert Hawes is a Gastroenterologist in Orlando, Florida. Dr. Hawes is highly rated in 31 conditions, according to our data. His top areas of expertise are Chronic Pancreatitis, Bile Duct Obstruction, Hereditary Pancreatitis, Endoscopy, and Lithotripsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lateef's expertise for a condition
ConditionClose
      View All 13 Advanced Conditions
      View All 54 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile